Patents by Inventor Jun-Ho La

Jun-Ho La has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of D9-methadone for postoperative pain relief
    Patent number: 12590054
    Abstract: Certain embodiments are directed to the use of d9-methadone as an alternative formulation for methadone, the d9-methadone having an improved absorption-distribution-metabolism-excretion profile, analgetic efficacy, and safety for the management of pain following injury such as trauma, disease, and surgery.
    Type: Grant
    Filed: December 22, 2022
    Date of Patent: March 31, 2026
    Assignee: Board of Regents, The University of Texas System
    Inventors: Tatiana N. Nanovskaya, Jun-Ho La, Mahmoud S. Ahmed, Jigong Wang
  • Non-opioid anti-pain medication
    Patent number: 12291553
    Abstract: The present invention relates to novel small molecules Formula I and pharmaceutically acceptable salts thereof as well as the preparation and the use thereof to inhibit FGF13-1b.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: May 6, 2025
    Inventors: Fernanda Laezza, Jia Zhou, Jin Mo Chung, Pingyuan Wang, Jun-Ho La, Oluwarotimi Folorunso, Aditya Singh
  • USE OF D9-METHADONE FOR POSTOPERATIVE PAIN RELIEF
    Publication number: 20240116851
    Abstract: Certain embodiments are directed to the use of d9-methadone as an alternative formulation for methadone, the d9-methadone having an improved absorption-distribution-metabolism-excretion profile, analgetic efficacy, and safety for the management of pain following injury such as trauma, disease, and surgery.
    Type: Application
    Filed: December 22, 2022
    Publication date: April 11, 2024
    Inventors: Tatiana N. Nanovskaya, Jun-Ho La, Mahmoud S. Ahmed, Jigong Wang
  • NOVEL NON-OPIOID ANTI-PAIN MEDICATION
    Publication number: 20220185855
    Abstract: The present invention relates to novel small molecules Formula I and pharmaceutically acceptable salts thereof as well as the preparation and the use thereof to inhibit FGF13-1b.
    Type: Application
    Filed: January 24, 2020
    Publication date: June 16, 2022
    Inventors: Fernanda Laezza, Jia Zhou, Jin Mo Chung, Plngyuan Wang, Jun-Ho La, Oluwarotimi Folorunso, Aditya Singh